JACOBS LEVY EQUITY MANAGEMENT, INC
Position in PCRX — Pacira BioSciences, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,068,926
+$815,923 QoQ
Shares Held
199,800
+6.2% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#41
of 251 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. PCRX ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
This page
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
4,273,026 | $4,871,249 |
All Filings in PCRX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,068,926 | 199,800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,253,003 | 188,186 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,411,893 | 170,475 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,816,986 | 652,580 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $23,535,333 | 984,742 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,258,876 | 855,488 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,558,277 | 454,261 | Shares | Sole | 2025-02-14 | |
| 2020-12-31 | $3,293,653 | 55,041 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,593,011 | 59,764 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,663,818 | 222,295 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $8,153,724 | 243,177 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||